Sigma Labs Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sigma Labs in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Sigma Labs stock.
View analyst ratings for Sigma Labs or view top-rated stocks.

Wall Street analysts have given Sigma Labs a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sigma Labs wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Sigma Labs saw a drop in short interest in August. As of August 31st, there was short interest totaling 781,800 shares, a drop of 20.6% from the August 15th total of 984,600 shares. Based on an average daily volume of 551,600 shares, the short-interest ratio is currently 1.4 days. Currently, 7.7% of the company's shares are short sold.
View Sigma Labs' Short Interest.

Sigma Labs is scheduled to release its next quarterly earnings announcement on Thursday, October 28th 2021.
View our earnings forecast for Sigma Labs.

Sigma Labs, Inc. (NASDAQ:SGLB) issued its quarterly earnings results on Thursday, July, 22nd. The company reported ($0.18) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.05. The company earned $0.14 million during the quarter, compared to analyst estimates of $0.59 million. Sigma Labs had a negative net margin of 509.70% and a negative trailing twelve-month return on equity of 50.72%.
View Sigma Labs' earnings history.

Sigma Labs' stock was trading at $4.76 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SGLB shares have decreased by 31.3% and is now trading at $3.27.
View which stocks have been most impacted by COVID-19.

1 equities research analysts have issued 1 year price objectives for Sigma Labs' stock. Their forecasts range from $6.00 to $6.00. On average, they expect Sigma Labs' stock price to reach $6.00 in the next year. This suggests a possible upside of 83.5% from the stock's current price.
View analysts' price targets for Sigma Labs or view top-rated stocks among Wall Street analysts.

Some companies that are related to Sigma Labs include Conversion Labs (CVLBD), VirTra (VTSI), Dogness (International) (DOGZ), Summer Infant (SUMR), Trans-Lux (TNLX), HempAmericana (HMPQ), Jason Industries (JASN), Jason Industries (JASNQ), Dais (DLYT), China Gengsheng Minerals (CHGS), Ingen Technologies (IGNT) and Kid Brands (KIDBQ).
View all of SGLB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sigma Labs investors own include Micron Technology (MU), Sorrento Therapeutics (SRNE), Ampio Pharmaceuticals (AMPE), Capricor Therapeutics (CAPR), Diffusion Pharmaceuticals (DFFN), OPKO Health (OPK), Trevena (TRVN), Allena Pharmaceuticals (ALNA), Advanced Micro Devices (AMD) and Bellerophon Therapeutics (BLPH).

Sigma Labs trades on the NASDAQ under the ticker symbol "SGLB."

Sigma Labs' stock is owned by a number of institutional and retail investors. Top institutional shareholders include AWM Investment Company Inc. (6.65%), Vanguard Group Inc. (1.25%), Essex Investment Management Co. LLC (0.99%), Geode Capital Management LLC (0.79%), Citadel Advisors LLC (0.00%) and Simplex Trading LLC (0.00%).
View institutional ownership trends for Sigma Labs.

SGLB stock was sold by a variety of institutional investors in the last quarter, including Wolverine Trading LLC, and Cutler Group LP.
View insider buying and selling activity for Sigma Labs or view top insider-selling stocks.

SGLB stock was purchased by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, AWM Investment Company Inc., Vanguard Group Inc., Geode Capital Management LLC, Simplex Trading LLC, State Street Corp, HAP Trading LLC, and Citadel Advisors LLC.
View insider buying and selling activity for Sigma Labs or or view top insider-buying stocks.

Shares of SGLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SGLB stock can currently be purchased for approximately $3.27.

Sigma Labs has a market capitalization of $34.32 million and generates $810,000.00 in revenue each year. The company earns $-5,200,000.00 in net income (profit) each year or ($1.83) on an earnings per share basis.

Sigma Labs employs 20 workers across the globe.

The official website for Sigma Labs is www.sigmalabsinc.com.

Sigma Labs is headquartered at 3900 PASEO DEL SOL, SANTA FE NM, 87507.

Sigma Labs' mailing address is 3900 PASEO DEL SOL, SANTA FE NM, 87507. The company can be reached via phone at (505) 438-2576 or via email at [email protected].